IL17A and differentiated thyroid carcinoma: Similarly, Carvalho et al. reported higher IL-17 expression in differentiated thyroid carcinoma than that of benign thyroid neoplasms and its association with high recurrence and morality as a pro-angiogenic mediator [26].